Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOld Mutual Lim. Regulatory News (OMU)

Share Price Information for Old Mutual Lim. (OMU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 47.50
Bid: 47.15
Ask: 47.55
Change: 0.05 (0.11%)
Spread: 0.40 (0.848%)
Open: 48.50
High: 48.50
Low: 47.05
Prev. Close: 47.45
OMU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Outcome of bondholder meetings

25 Oct 2018 14:10

RNS Number : 2137F
Old Mutual Limited
25 October 2018
 

Old Mutual Limited

Incorporated in the Republic of South Africa

Registration number: 2017/235138/06

ISIN: ZAE000255360

LEI: 213800MON84ZWWPQCN47

JSE Share Code: OMU

NSX Share Code: OMM

("Old Mutual")

 

 

Ref 72_18

25 October 2018

NOT FOR DISTRIBUTION INTO ANY JURISDICTION OR TO ANY PERSON WHERE OR TO WHOM IT IS UNLAWFUL TO DISTRIBUTE THIS DOCUMENT.

 

OUTCOMES OF BONDHOLDER MEETINGS

 

OLD MUTUAL SUBSIDIARY OLD MUTUAL PLC ANNOUNCES THE CONVENING OF ADJOURNED NOTEHOLDER MEETINGS AND THE OUTCOME OF SEPARATE NOTEHOLDER MEETINGS OF ITS OUTSTANDING £500,000,000 8 PER CENT. SUBORDINATED NOTES DUE 3 JUNE 2021 AND ITS OUTSTANDING £450,000,000 7.875 PER CENT. SUBORDINATED NOTES DUE 3 NOVEMBER 2025 TO APPROVE BY WAY OF EXTRAORDINARY RESOLUTION CERTAIN MODIFICATIONS TO THE TERMS AND CONDITIONS OF THE RELEVANT SERIES AND THE RELEVANT TRUST DEED CONSTITUTING THE RELEVANT SERIES

 

The body of the Old Mutual plc announcement (as published on the London Stock Exchange website) is set out below.

----------------------------------------------------------------------------------------------------------------------------------

Old Mutual plc (the "Company") announces THE CONVENING OF ADJOURNED NOTEHOLDER MEETINGS AND THE OUTCOME of SEPARATE NOTEHOLDER MEETINGs of its outstanding £500,000,000 8 PER CENT. SUBORDINATED NOTES DUE 3 JUNE 2021 (the "2021 Securities") AND ITS OUTSTANDING £450,000,000 7.875 PER CENT. SUBORDINATED NOTES DUE 3 NOVEMBER 2025 (the "2025 Securities" and, together with the 2021 Securities, the "Securities", and each a "Series") to approve by way of extraordinary resolution certain modifications to the terms and conditions of the relevant series and the relevant trust deed constituting the relevant series

 

On 26 September 2018, the Company announced its separate invitations to holders of its 2021 Securities (the "2021 Securityholders") and to holders of its 2025 Securities (the "2025 Securityholders" and, together with the 2021 Securityholders, the "Securityholders") in each case to approve, by way of Extraordinary Resolution, the relevant Proposal, comprising certain modifications to the terms and conditions of the relevant Series (in respect of such Series, the "Conditions") and the trust deed constituting the relevant Series as further detailed in the Consent Solicitation Memorandum dated 26 September 2018 (the "Consent Solicitation Memorandum"), subject, in each case, to the terms and conditions set out in the Consent Solicitation Memorandum as amended by this announcement (see below). Copies of the Consent Solicitation Memorandum are available from the Tabulation Agent as set out below. Capitalised terms used in this announcement but not defined have the meanings given to them in the Consent Solicitation Memorandum.

Results of the Proposals

The Meetings to consider the Proposals were held earlier today, and NOTICE IS HEREBY GIVEN to Securityholders that:

(a) the Meeting in relation to the 2021 Securities was not quorate and has therefore been adjourned until 10.00 a.m. (London time) on 12 November 2018 to be held at the offices of Linklaters LLP, One Silk Street, London EC2Y 8HQ (the "2021 Securities Adjourned Meeting");

(b) the Meeting in relation to the 2025 Securities was not quorate and has therefore been adjourned until 10.15 a.m. (London time) on 12 November 2018 to be held at the offices of Linklaters LLP, One Silk Street, London EC2Y 8HQ (the "2025 Securities Adjourned Meeting", and, together with the 2021 Securities Adjourned Meeting, the "Adjourned Meetings", and each an "Adjourned Meeting"); and

(c) pursuant to the terms of the Consent Solicitation Memorandum, the Company hereby announces that the Consent Deadline in respect of the Securities will be extended to 4.00 p.m. (London time) on 7 November 2018 to provide Securityholders with further time to deliver, or arrange to have delivered on their behalf, a valid Solicitation Instruction in favour of the relevant Extraordinary Resolution in order to be eligible to receive the Consent Fee. As such, Securityholders may continue to submit Solicitation Instructions up to 4.00 p.m. (London time) on 7 November 2018. Securityholders who deliver, or arrange to have delivered on their behalf, a valid Solicitation Instruction in favour of the relevant Extraordinary Resolution which are received by the Tabulation Agent by the Consent Deadline will be eligible to receive the Consent Fee.

Notices convening the Adjourned Meetings shall be given to Securityholders in accordance with the relevant Trust Deed on the date of this announcement.

Solicitation Instructions previously submitted in accordance with the procedures set out in the Consent Solicitation Memorandum and which have not been subsequently validly revoked (in the limited circumstances in which such revocation is permitted) shall remain valid for the relevant Adjourned Meeting and, for avoidance of doubt, no further action is required from Securityholders who previously submitted such Solicitation Instructions. The results of the Adjourned Meetings are expected to be announced as soon as reasonably practicable after the Adjourned Meetings.

Securityholders should refer to the relevant Notice for full details of the procedures in relation to the relevant Adjourned Meeting.

General

Securityholders are advised to check with any bank, securities broker or other intermediary through which they hold their Securities when such intermediary would need to receive instructions from a Securityholder in order for such Securityholder to participate in, or (in the limited circumstances in which revocation is permitted) to validly revoke their instruction to participate in, the Consent Solicitation and/or vote in respect of either or both of the Proposals before the deadlines specified above. The deadlines set by any such intermediary and each Clearing System for the submission and (where permitted) revocation of Solicitation Instructions will be earlier than the relevant deadlines above and in the Consent Solicitation Memorandum.

Unless stated otherwise, announcements in connection with the Consent Solicitation and the Proposals will be made (i) by publication via RNS and (ii) by the delivery of notices to the Clearing Systems for communication to Direct Participants. Such announcements may also be made on the relevant Reuters Insider Screen and by the issue of a press release to a Notifying News Service. Copies of all such announcements, notices and press releases can also be obtained upon request from the Tabulation Agent.

In addition to this announcement, Securityholders are advised to read carefully the Consent Solicitation Memorandum for full details of and information on the procedures for participating in the Consent Solicitation.

Requests for information in relation to the Consent Solicitation and the Proposals should be directed to:

The Solicitation Agent

Merrill Lynch International2 King Edward StreetLondon EC1A 1HQUnited Kingdom

Telephone: +44 20 7996 5420Attention: Liability Management GroupEmail: DG.LM_EMEA@baml.com

 

Requests for information in relation to the submission of a Solicitation Instruction in favour of either Proposal should be directed to:

The Tabulation Agent

Lucid Issuer Services LimitedTankerton Works12 Argyle WalkLondon WC1H 8HAUnited Kingdom

Telephone: + 44 20 7704 0880Attention: Arlind BytyqiEmail: oldmutual@lucid-is.com

DISCLAIMER This announcement must be read in conjunction with the Consent Solicitation Memorandum. No offer or invitation to acquire any securities is being made pursuant to this announcement.

This announcement and Consent Solicitation Memorandum contain important information which should be read carefully before any decision is made with respect to the Consent Solicitation and the Proposal. If any Securityholder is in any doubt as to the action it should take, it is recommended to seek its own financial and legal advice, including in respect of any tax consequences, immediately from its broker, bank manager, solicitor, accountant or other independent financial, tax or legal adviser. Any individual or company whose Securities are held on its behalf by a broker, dealer, bank, custodian, trust company or other nominee or intermediary must contact such entity if it wishes to participate in the Consent Solicitation or otherwise vote in respect of either or both of the Proposals. None of the Company, the Solicitation Agent, the Tabulation Agent, the Principal Paying Agent, the Registrar, the Trustee or any of their respective agents, directors, employees, representatives or affiliates makes any representation or recommendation as to whether Securityholders should participate in the Consent Solicitation or otherwise vote in respect of the relevant Proposal. The distribution of this announcement and the Consent Solicitation Memorandum in certain jurisdictions may be restricted by law. Persons into whose possession this announcement and/or the Consent Solicitation Memorandum comes are required by each of the Company, the Solicitation Agent and the Tabulation Agent to inform themselves about, and to observe, any such restrictions.

Nothing in this announcement and/or the Consent Solicitation Memorandum constitutes or contemplates an offer of, an offer to purchase or the solicitation of an offer to purchase or sell any security in the United States or in any other jurisdiction.

 

 

----------------------------------------------------------------------------------------------------------------------------------

 

JSE Sponsor: Merrill Lynch South Africa (Pty) Limited

Namibian Sponsor: PSG Wealth Management (Namibia) (Proprietary) Limited

 

Enquiries

Investor Relations

Patrick Bowes (Interim Head of Investor Relations)

 

T: +44 (0)20 7002 7440

E: patrick.bowes@omg.co.uk

Communications:

Tabby Tsengiwe

 

T: +27 (11) 217 1953

M: +27 (0)60 547 4947

E: ttsengiwe@oldmutual.com

 

Notes to Editors

 

About Old Mutual Limited

 

Old Mutual is a premium African financial services group that offers a broad spectrum of financial solutions to retail and corporate customers across key markets segments in 17 countries. Old Mutual's primary operations are in South Africa and the rest of Africa, and it has niche businesses in Latin America and Asia. With over 170 years of heritage across sub-Saharan Africa, we are a crucial part of the communities we serve and broader society on the continent.

 

For further information on Old Mutual, and its underlying businesses, please visit the corporate website at www.oldmutual.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCLLFSFITLEFIT
Date   Source Headline
26th Jul 20224:00 pmRNSDirectorate Change
26th Jul 20221:00 pmRNSForm 8.3 - Mediclinic International plc
25th Jul 20221:00 pmRNSForm 8.3 - Mediclinic International plc
19th Jul 20222:00 pmRNSForm 8.3 - Mediclinic International plc
18th Jul 20221:00 pmRNSForm 8.3 - Mediclinic International plc
15th Jul 202211:15 amRNSLiving Hands Trust Matter
13th Jul 20221:00 pmRNSForm 8.3 - Mediclinic International plc
13th Jul 202212:00 pmRNSDistribution of circular including notice of GM
7th Jul 20221:30 pmRNSForm 8.3 - Mediclinic International plc
24th Jun 20223:30 pmRNSHolding(s) in Company
23rd Jun 20222:00 pmRNSForm 8.3 - Mediclinic International plc
22nd Jun 20222:00 pmRNSForm 8.3 - Mediclinic International plc
22nd Jun 202211:45 amRNSOMLACSA new financial instrument
20th Jun 20223:00 pmRNSForm 8.3 - Mediclinic International plc
16th Jun 20221:00 pmRNSForm 8.3 - Mediclinic International plc
15th Jun 20221:00 pmRNSForm 8.3 - Mediclinic International plc
13th Jun 20221:00 pmRNSForm 8.3 - Mediclinic International plc
10th Jun 20224:00 pmRNSForm 8.3 - Mediclinic International plc
6th Jun 20223:45 pmRNSDisposal of Securities by BlackRock. Inc
27th May 202212:15 pmRNSResult of AGM
26th May 202211:00 amRNSOld Mutual Voluntary Operating Update
26th Apr 20222:30 pmRNSNotice of AGM
26th Apr 20229:00 amRNSDirector/PDMR Shareholding
25th Apr 20221:30 pmRNSDealings in Securities
25th Apr 202210:10 amRNSDealings in securities
22nd Apr 20227:00 amRNSRelease of the IR and investor engagement
20th Apr 20222:00 pmRNSOML proposed Bula Tsela B-BBEE transaction
14th Apr 20223:00 pmRNSDealings in Securities on behalf of ESIS
14th Apr 20229:00 amRNSDealings in securities on behalf of ESIS
11th Apr 20222:00 pmRNSDealings in securities on behalf of ESIS
31st Mar 20229:00 amRNSBEE certificate and annual compliance report
25th Mar 20227:30 amRNSAcquisition of securities by BlackRock Inc
24th Mar 202212:30 pmRNSDisposal of Securities by clients of Allan Gray
24th Mar 20227:00 amRNSNo change statement
22nd Mar 20228:30 amRNSFinalisation & Dividend Currency Equivalents
15th Mar 20227:00 amRNSReviewed annual results and dividend declaration
23rd Feb 20227:00 amRNSTrading Statement
13th Dec 20213:00 pmRNSSecurities dealing on behalf of a share trust
10th Dec 20212:30 pmRNSDealings in securities on behalf of LTIP
10th Dec 20212:30 pmRNSDealings in Securities on behalf of ESOP
3rd Dec 202110:00 amRNSDealings in securities on behalf of Share Trusts
23rd Nov 20217:00 amRNSVoluntary Operating Update
19th Nov 202111:00 amRNSDealings in securities on behalf of share trusts
17th Nov 202112:00 pmRNSSecurities dealing on behalf of share trusts
12th Nov 20212:30 pmRNSSecurities dealing on behalf of Share Trusts
4th Nov 20218:00 amRNSCash proceeds - fractional entitlements
26th Oct 20219:00 amRNSFinalisation: Unbundling by OMU of portion of NED
22nd Sep 20212:01 pmRNSNew financial instrument listing
7th Sep 20218:30 amRNSOML Dividend Currency Equivalents
31st Aug 20214:30 pmRNSInvitation to shareholders

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.